Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa
Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation...
Gespeichert in:
Veröffentlicht in: | Journal of medical microbiology 2020-02, Vol.69 (2), p.195-206 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 206 |
---|---|
container_issue | 2 |
container_start_page | 195 |
container_title | Journal of medical microbiology |
container_volume | 69 |
creator | Proctor, Chris R McCarron, Paul A Ternan, Nigel G |
description | Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as
QS inhibitors (QSIs).
is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both
and
we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions. |
doi_str_mv | 10.1099/jmm.0.001144 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2344228907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2344228907</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</originalsourceid><addsrcrecordid>eNo90DtPwzAYhWELgWgpbMzIIwMpvibxiCoKSJVggDlyki-tq8RufQHx7wlqYTrLozO8CF1TMqdEqfvtMMzJnBBKhThBUyoKnslciFM0JYSxjOVUTtBFCNvRFJyrczThVBVUEj5F3TJ5bZ0FvE_OpyELYIOxa2zsxtQmOh_wl4kbvHMRbDS6xzpg6z6hx3EDXu8gRdMErNfa2BDxW4DUusHZkWnwaW2sC_oSnXW6D3B13Bn6WD6-L56z1evTy-JhlTWcqZjptpGcFm1T1IqWou4awQB0kZeS5QRq1lJR1nmRK17mZU05b2lTaia7XEolOZ-h28Pvzrt9ghCrwYQG-l5bcClUjAvBWKlIMdK7A228C8FDV-28GbT_riipfstWY9mKVIeyI785Pqd6gPYf_6XkPyLidhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2344228907</pqid></control><display><type>article</type><title>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</title><source>MEDLINE</source><source>Microbiology Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Proctor, Chris R ; McCarron, Paul A ; Ternan, Nigel G</creator><creatorcontrib>Proctor, Chris R ; McCarron, Paul A ; Ternan, Nigel G</creatorcontrib><description>Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as
QS inhibitors (QSIs).
is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both
and
we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions.</description><identifier>ISSN: 0022-2615</identifier><identifier>EISSN: 1473-5644</identifier><identifier>DOI: 10.1099/jmm.0.001144</identifier><identifier>PMID: 31971503</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - chemistry ; Furans - administration & dosage ; Furans - chemistry ; Humans ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - genetics ; Pseudomonas aeruginosa - physiology ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - microbiology ; Quorum Sensing - drug effects</subject><ispartof>Journal of medical microbiology, 2020-02, Vol.69 (2), p.195-206</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</citedby><cites>FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</cites><orcidid>0000-0002-0036-7123 ; 0000-0002-1788-7571 ; 0000-0002-2292-9887</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3733,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31971503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Proctor, Chris R</creatorcontrib><creatorcontrib>McCarron, Paul A</creatorcontrib><creatorcontrib>Ternan, Nigel G</creatorcontrib><title>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</title><title>Journal of medical microbiology</title><addtitle>J Med Microbiol</addtitle><description>Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as
QS inhibitors (QSIs).
is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both
and
we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Furans - administration & dosage</subject><subject>Furans - chemistry</subject><subject>Humans</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - genetics</subject><subject>Pseudomonas aeruginosa - physiology</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Quorum Sensing - drug effects</subject><issn>0022-2615</issn><issn>1473-5644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90DtPwzAYhWELgWgpbMzIIwMpvibxiCoKSJVggDlyki-tq8RufQHx7wlqYTrLozO8CF1TMqdEqfvtMMzJnBBKhThBUyoKnslciFM0JYSxjOVUTtBFCNvRFJyrczThVBVUEj5F3TJ5bZ0FvE_OpyELYIOxa2zsxtQmOh_wl4kbvHMRbDS6xzpg6z6hx3EDXu8gRdMErNfa2BDxW4DUusHZkWnwaW2sC_oSnXW6D3B13Bn6WD6-L56z1evTy-JhlTWcqZjptpGcFm1T1IqWou4awQB0kZeS5QRq1lJR1nmRK17mZU05b2lTaia7XEolOZ-h28Pvzrt9ghCrwYQG-l5bcClUjAvBWKlIMdK7A228C8FDV-28GbT_riipfstWY9mKVIeyI785Pqd6gPYf_6XkPyLidhw</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Proctor, Chris R</creator><creator>McCarron, Paul A</creator><creator>Ternan, Nigel G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0036-7123</orcidid><orcidid>https://orcid.org/0000-0002-1788-7571</orcidid><orcidid>https://orcid.org/0000-0002-2292-9887</orcidid></search><sort><creationdate>202002</creationdate><title>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</title><author>Proctor, Chris R ; McCarron, Paul A ; Ternan, Nigel G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-adc5317dc7b9184bfc42eea7685260eb2d148b67693868b133d1c8a25f6559533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Furans - administration & dosage</topic><topic>Furans - chemistry</topic><topic>Humans</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - genetics</topic><topic>Pseudomonas aeruginosa - physiology</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Quorum Sensing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Proctor, Chris R</creatorcontrib><creatorcontrib>McCarron, Paul A</creatorcontrib><creatorcontrib>Ternan, Nigel G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Proctor, Chris R</au><au>McCarron, Paul A</au><au>Ternan, Nigel G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa</atitle><jtitle>Journal of medical microbiology</jtitle><addtitle>J Med Microbiol</addtitle><date>2020-02</date><risdate>2020</risdate><volume>69</volume><issue>2</issue><spage>195</spage><epage>206</epage><pages>195-206</pages><issn>0022-2615</issn><eissn>1473-5644</eissn><abstract>Micro-organisms use quorum sensing (QS), a cell density-dependent process, to communicate. This QS mode of interchange leads to the production of a variety of virulence factors, co-ordination of complex bacterial behaviours, such as swarming motility, degradation of host tissue and biofilm formation. QS is implicated in numerous human infections and consequently researchers have sought ways of effectively inhibiting the process in pathogenic bacteria. Two decades ago, furanones were the first class of chemical compounds identified as
QS inhibitors (QSIs).
is a ubiquitous organism, capable of causing a wide range of infections in humans, including eye and ear infections, wound infections and potentially fatal bacteraemia and thus novel treatments against this organism are greatly needed. This review provides a brief background on QS and the use of furanones as QSIs. Based on the effectiveness of action, both
and
we will explore the use of furanones as potential antimicrobial therapeutics and conclude with open questions.</abstract><cop>England</cop><pmid>31971503</pmid><doi>10.1099/jmm.0.001144</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0036-7123</orcidid><orcidid>https://orcid.org/0000-0002-1788-7571</orcidid><orcidid>https://orcid.org/0000-0002-2292-9887</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2615 |
ispartof | Journal of medical microbiology, 2020-02, Vol.69 (2), p.195-206 |
issn | 0022-2615 1473-5644 |
language | eng |
recordid | cdi_proquest_miscellaneous_2344228907 |
source | MEDLINE; Microbiology Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - chemistry Furans - administration & dosage Furans - chemistry Humans Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - genetics Pseudomonas aeruginosa - physiology Pseudomonas Infections - drug therapy Pseudomonas Infections - microbiology Quorum Sensing - drug effects |
title | Furanone quorum-sensing inhibitors with potential as novel therapeutics against Pseudomonas aeruginosa |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A32%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Furanone%20quorum-sensing%20inhibitors%20with%20potential%20as%20novel%20therapeutics%20against%20Pseudomonas%20aeruginosa&rft.jtitle=Journal%20of%20medical%20microbiology&rft.au=Proctor,%20Chris%20R&rft.date=2020-02&rft.volume=69&rft.issue=2&rft.spage=195&rft.epage=206&rft.pages=195-206&rft.issn=0022-2615&rft.eissn=1473-5644&rft_id=info:doi/10.1099/jmm.0.001144&rft_dat=%3Cproquest_cross%3E2344228907%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2344228907&rft_id=info:pmid/31971503&rfr_iscdi=true |